Exploring how cancer stem cells hold the key to curing cancer and the innovative therapies companies are developing to target these resilient cells.
Discover how scientists are identifying novel BCR-ABL splice variants in Philadelphia-negative leukemias and developing targeted immunotherapies to combat these shape-shifting cancer proteins.
Exploring the breakthrough immunotherapy flotetuzumab for relapsed/refractory acute myeloid leukemia (AML) - mechanism, clinical trial results, and future directions.
Discover how genetic engineering of monocytes creates a revolutionary approach to combat breast cancer by turning tumor-supporting cells into cancer-killing agents.
Explore the revolutionary progress in cancer therapy, from chemotherapy to intelligent immunotherapies that train the body's immune system to fight cancer.
Discover how the CS1 protein is revolutionizing multiple myeloma treatment through targeted immunotherapy approaches like elotuzumab.
Discover how scientists are developing precision-guided immunotherapies targeting the B7-H3 protein to fight cancer with fewer side effects.
Discover how Raji Burkitt lymphoma cells are revolutionizing CD52-targeted immunotherapy research and cancer treatment development.
Explore how DNA transposons revolutionize T-cell engineering for cancer immunotherapy, offering safer and more affordable alternatives to viral vectors.
How the body's molecular recycling system holds the key to unleashing immune cells against tumors through ubiquitination pathways.